Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | Datamonitor Healthcare Reports | Commercial Insight: Select herpes viruses and human papilloma virus - Non-biologic interventions for oral and genital herpes, cytomegalovirus infection, herpes zoster and genital warts

Commercial Insight: Select herpes viruses and human papilloma virus - Non-biologic interventions for oral and genital herpes, cytomegalovirus infection, herpes zoster and genital warts

Despite high unmet need, the market for the small molecules used to manage conditions such as genital and oral herpes, genital warts, cytomegalovirus retinitis and pneumonia or shingles has been neglected compared with the successfully promoted immunizations for varicella in children, zoster in adults, or human papilloma virus in adolescents.

Scope

*Market overview of available treatments for four viral pathogens

*Assessment of brand dynamics for major players

*Comparative assessment of strengths and weaknesses in current and future competitive environment

*Ten year sales volume and value forecast for the 7 Major Markets by brand, molecule and region

Highlights

Current formulary reimbursement restrictions on valaciclovir could be overturned if generic rivals to Valtrex were launched at a dramatic discount rather than the commonly applied practice of charging highest achievable price , replacing acyclovir as the most popular drug in the process.

The level of unmet need in all four disease markets is still substantial, opening up substantial opportunities for true innovations in an otherwise highly genericised competitive environment characterized by high volume, low value offerings. The few existing late-stage development pipeline compounds will not be able to benefit.

While the seven Major Markets currently dominate the commercial landscape, the ROW offers huge scope for market expansion. While pricing levels are far lower, commodity products such as antivirals and antibacterials are an ideal platform for branded Pharma to increase their presence in Emerging Markets.

Reasons to Purchase

*Identify key opportunities and threats that will impact the use and uptake of branded and generic products

*Select effective lifecycle management strategies through analysis of key brand strategies

*Understand and capitalize on clinical unmet needs in the market, either through lifecycle management of marketed drugs or new product development

26-Aug-08 PDF & SlidePack & DataPack Pages: 270

Table of Contents
Price: $15,200.00 / €10,159.68

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions